Clinical Trial Update: Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy [Phase 3]

View source ↗

Summary

A Phase 3 double-blind trial evaluating sodium thiosulfate for pain in calciphylaxis (calcific uremic arteriolopathy) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcific Uremic Arteriolopathy
• Calciphylaxis

Drugs mentioned

• Sodium thiosulfate (sodium thiosulfate)

Snippet

Sponsor: American Regent, Inc. | Conditions: Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 3 | Status: WITHDRAWN